Regulatory Expectations for Peptide Mapping in GLP-1 Generic Drug Development

Introduction: GLP-1 Peptide Mapping Regulatory Requirements are central to demonstrating biosimilarity and structural integrity in generic drug development. Regulatory authorities … Continue reading Regulatory Expectations for Peptide Mapping in GLP-1 Generic Drug Development